Baseline HBsAg predicts response to pegylated interferon-&alpha;2b in HBeAg-positive chronic hepatitis B patients

doi:10.3748/wjg.v20.i25.8195

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 25

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5181)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

412

WORD

237

HTML

2676

Figures (1-1)

156

Tables (1-2)

120

Sum=3601

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

842

Download

738

Sum=1580

Jul 7, 2014 (publication date) through May 5, 2024

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Jul 7, 2014; 20(25): 8195-8200
Published online Jul 7, 2014. doi: 10.3748/wjg.v20.i25.8195

Open in New Tab Full Size Figure Download Figure

Figure 1 Correlation between baseline serum hepatitis B surface antigen (HBsAg) levels and serum hepatitis B virus DNA levels. HBsAg: Hepatitis B surface antigen; HBV: Hepatitis B virus.

Citation: Chen GY, Zhu MF, Zheng DL, Bao YT, Wang J, Zhou X, Lou GQ. Baseline HBsAg predicts response to pegylated interferon-α2b in HBeAg-positive chronic hepatitis B patients. World J Gastroenterol 2014; 20(25): 8195-8200
URL: https://www.wjgnet.com/1007-9327/full/v20/i25/8195.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i25.8195